A detailed history of Sei Investments CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Sei Investments CO holds 489,189 shares of LLY stock, worth $429 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
489,189
Previous 465,497 5.09%
Holding current value
$429 Million
Previous $362 Million 22.3%
% of portfolio
0.64%
Previous 0.54%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $17.2 Million - $21.5 Million
23,692 Added 5.09%
489,189 $443 Million
Q1 2024

May 07, 2024

SELL
$592.2 - $792.28 $466,061 - $623,524
-787 Reduced 0.17%
465,497 $362 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $3.77 Million - $4.44 Million
-7,173 Reduced 1.52%
466,284 $272 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $16 Million - $22.1 Million
36,821 Added 8.43%
473,457 $254 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $29 Million - $38.8 Million
82,691 Added 23.36%
436,636 $205 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $18 Million - $21.1 Million
57,891 Added 19.55%
353,945 $122 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $20.7 Million - $24.1 Million
-64,456 Reduced 17.88%
296,054 $108 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $1.33 Million - $1.51 Million
4,475 Added 1.26%
360,510 $117 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $5.86 Million - $6.88 Million
21,034 Added 6.28%
356,035 $116 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $3.14 Million - $3.91 Million
13,389 Added 4.16%
335,001 $96.2 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $3.45 Million - $4.28 Million
15,326 Added 5.0%
321,612 $89 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $629,787 - $775,041
2,842 Added 0.94%
306,286 $70.5 Million
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $4.75 Million - $6.15 Million
-26,330 Reduced 7.98%
303,444 $69.6 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $29.2 Million - $37.8 Million
-177,488 Reduced 34.99%
329,774 $60.6 Million
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $755,102 - $999,182
5,788 Added 1.15%
507,262 $85.7 Million
Q3 2020

Dec 04, 2020

SELL
$146.22 - $169.13 $1.15 Million - $1.33 Million
-7,837 Reduced 1.54%
501,474 $74.2 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $10 Million - $11.6 Million
-68,413 Reduced 11.84%
509,311 $75.3 Million
Q2 2020

Aug 17, 2020

BUY
$136.42 - $164.18 $19.9 Million - $24 Million
146,206 Added 33.88%
577,724 $94.7 Million
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $12.4 Million - $15 Million
-91,165 Reduced 17.44%
431,518 $58.6 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $13.7 Million - $16.9 Million
114,950 Added 28.19%
522,683 $72.5 Million
Q4 2019

Feb 06, 2020

SELL
$106.92 - $132.43 $6.42 Million - $7.96 Million
-60,071 Reduced 12.84%
407,733 $53.6 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $3.37 Million - $3.66 Million
31,538 Added 7.23%
467,804 $52.2 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $18.6 Million - $21.7 Million
-168,055 Reduced 27.81%
436,266 $48.3 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $4.32 Million - $5.08 Million
38,779 Added 6.86%
604,321 $78.5 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $2.16 Million - $2.42 Million
20,384 Added 3.74%
565,542 $61.3 Million
Q3 2018

Nov 08, 2018

SELL
$85.86 - $107.31 $6.53 Million - $8.17 Million
-76,099 Reduced 12.25%
545,158 $58.5 Million
Q2 2018

Aug 03, 2018

SELL
$75.7 - $86.88 $2.24 Million - $2.58 Million
-29,656 Reduced 4.56%
621,257 $53 Million
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $37.4 Million - $44.1 Million
-503,703 Reduced 43.63%
650,913 $50.4 Million
Q4 2017

Feb 08, 2018

SELL
$81.94 - $87.89 $11.3 Million - $12.1 Million
-138,156 Reduced 10.69%
1,154,616 $97.5 Million
Q3 2017

Nov 06, 2017

BUY
$77.07 - $85.54 $99.6 Million - $111 Million
1,292,772
1,292,772 $111 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.